Diagnostic performance of [¹⁸F]-FDG PET/MR in evaluating colorectal cancer: a systematic review and meta-analysis

CONCLUSION: This meta-analysis showed an overall high diagnostic performance for [^(18)F]-FDG PET/MR in detecting CRC lesions/metastases. Thus, this modality can play a significant role in several clinical scenarios in CRC staging and restaging. Specifically, one of the main strengths of this modality is ruling out the existence of CRC lesions/metastases. Finally, the overall diagnostic performance was not found to be affected in the post-treatment setting.